North America Respiratory Care Devices Market Outlook, 2028

Respiratory care devices are pieces of medical equipment used to diagnose, monitor, and care for individuals suffering from respiratory disorders such as asthma, pneumonia, or tuberculosis. Positive airway pressure (PAP) devices, nebulizers, inhalers, humidifiers, and spirometers are among the respiratory devices. The rise in preterm birth occurrences and lifestyle changes has increased the frequency of numerous ailments, which are projected to drive the growth of the respiratory care devices market over the forecast period. Furthermore, rising cigarette smoking rates and an increase in the elderly and obese population in North America are expected to drive the growth of the respiratory care devices market. Telemedicine has grown in popularity in North America, particularly since the COVID-19 pandemic. Telehealth technologies are increasingly being used by respiratory care physicians to perform virtual consultations and remotely monitor patients with chronic respiratory disorders. This trend increases not only access to care but also patient compliance and results. The demand for sophisticated ventilation solutions has increased in the respiratory care equipment industry. High-tech ventilators with capabilities such as adaptive algorithms, pressure support, and greater patient-ventilator synchronization are becoming more common. These devices are critical in the treatment of patients suffering from severe respiratory diseases, notably those in intensive care units. Data analytics and artificial intelligence (AI) are being used to improve respiratory disease diagnosis and management. Large quantities of patient information can be analyzed by machine learning algorithms to find trends, forecast exacerbations, and optimize treatment approaches. These devices are especially beneficial for chronic respiratory illnesses. Advancements in miniaturization and sensor technology have led to the development of portable and wearable respiratory care devices. These include compact spirometers, oximeters, and smart inhalers that provide real-time data and facilitate continuous monitoring, empowering patients to take a more active role in managing their respiratory health.

According to the research report, “North America Respiratory Care Devices Market Outlook, 2028” the market was valued more than USD 7 Billion in 2022. Asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea are among the most common respiratory disorders in North America. Because of the increased disease load, there is a greater demand for respiratory care devices such as ventilators, oxygen treatment equipment, and inhalers. The region has a well-developed healthcare infrastructure that includes access to cutting-edge medical facilities, trained healthcare experts, and cutting-edge technology. This infrastructure promotes the quick adoption of innovative respiratory care solutions and guarantees that these devices are available to patients as soon as possible. Healthcare systems in North America, particularly in the United States, rely on a mix of public and private insurance models. These reimbursement schemes have a significant impact on the respiratory care equipment business, influencing pricing, patient access, and the adoption of innovative technologies. North American patients are generally well-informed about their healthcare alternatives and have access to a variety of health information. This degree of awareness and patient engagement enables people to take an active role in their respiratory treatment, which leads to a stronger adoption of at-home equipment and self-monitoring solutions. Cross-border collaboration in healthcare research, development, and innovation helps North America. The proximity of the United States and Canada encourages collaboration among medical institutions, industries, and government agencies, hastening the pace of technical developments in respiratory treatment. North America is routinely ranked among the regions with the highest per capita healthcare expenditures in the world. This significant healthcare spending allows the region to invest in sophisticated respiratory care equipment and therapies, ensuring patients have a variety of options. North America conducts a large percentage of global clinical studies, particularly those involving respiratory care devices. Because regulatory approvals frequently require significant clinical testing, this enables the entry of new and innovative products into the market. Medical tourists seeking advanced respiratory care treatments flock to the region. High-quality healthcare facilities, renowned medical professionals, and cutting-edge technologies make North America an appealing destination for people seeking respiratory care from all over the world.

Based on report market is divided into three major countries United, Canada and Mexico. Among them market is majorly dominated by United States with significant market share.

The United States is North America's most populous country, and its size creates a sizable patient base for respiratory care products. There is a rising demand for these devices as the prevalence of respiratory disorders such as asthma, COPD, and sleep apnea rises due to factors such as air pollution and lifestyle choices. The country has a sophisticated and comprehensive healthcare system, which includes hospitals, clinics, and research facilities. These facilities are well-equipped to deliver top-tier respiratory care treatments and have access to cutting-edge technology. Integration of respiratory care devices with telehealth platforms would enable remote monitoring and consultation, providing patients with real-time assistance while reducing the burden on healthcare facilities. The United States is a center for medical technology innovation. Companies in the United States are at the forefront of developing and manufacturing novel respiratory care products that include cutting-edge technology. This includes devices with advanced sensors, data networking, and user-friendly interfaces. The United States invests heavily in healthcare research and development. As a result of this dedication to innovation, respiratory care technologies are always evolving. American research institutes and schools collaborate with industry leaders to drive advancements in this field. The United States makes significant investments in medical research and development, both through government institutions such as the National Institutes of Health (NIH) and commercial groups.

Based on product type market includes therapeutic devices, monitoring devices, diagnostic devices and consumables and accessories. Among them therapeutic devices accounted for largest market in North America.

Chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea are common in North America. Therapeutic devices are essential in the diagnosis and treatment of various disorders. Patients with COPD, for instance, require oxygen therapy and nebulizers for drug delivery, whereas people with sleep apnea rely on continuous positive airway pressure (CPAP) machines to keep their airways open while sleeping. The sheer number of patients suffering from these chronic diseases fuels the market for therapeutic devices. The region's population is aging, and elderly people are more vulnerable to respiratory illnesses. As the older population grows, so does the demand for therapeutic devices that provide respiratory support and relieve symptoms associated with age-related illnesses. Collaboration among healthcare practitioners, medical device makers, and pharmaceutical corporations has resulted in the creation of integrated solutions that combine therapeutic devices with pharmaceuticals and therapies, ultimately improving patient outcomes. Air pollution and climate change, for example, can aggravate respiratory disorders. Individuals are more willing to invest in therapeutic gadgets to preserve their respiratory health as environmental worries develop. Medical device companies in North America frequently export their products to other regions, and international demand for high-quality therapeutic devices has contributed to market growth.

Based on disease indication market include chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases and other disease indications. Furthermore based on end user market is divided into hospitals, ambulatory care centers (ACCs), home care settings and other end user.

Chronic obstructive pulmonary disease (COPD) is major disease indication for respiratory care devices in North America. COPD is one of the most common respiratory disorders in the United States. COPD affects millions of people in the United States and Canada, and its incidence is increasing. Because of the high prevalence, there is a great demand for respiratory care devices to control and treat the condition. COPD is a chronic illness marked by persistent airflow restriction that frequently necessitates long-term care and treatment. Patients with COPD frequently require respiratory care equipment to help them breathe and enhance their quality of life. Smoking is a significant risk factor for COPD, and despite reducing smoking rates, a sizable fraction of the North American population has a smoking history. Former smokers and others who have a history of smoking-related lung disease frequently require respiratory care devices to manage their COPD symptoms. Hospitals are the major end users of Respiratory care devices in North America and is dominating the market as well. Acute care for patients with severe respiratory problems is provided by hospitals. They care for people who have acute exacerbations of chronic respiratory disorders such as COPD, pneumonia, and asthma, as well as people who are in respiratory distress due to infections, trauma, or surgery. Respiratory care equipment is critical for managing and stabilizing these severe illnesses. Patients may require respiratory care equipment after surgery to help them breathe while they recover from anesthesia. These devices aid in the prevention of postoperative problems and assist patients in regaining full lung function. Diagnostic tests for respiratory health, such as pulmonary function testing, arterial blood gas analysis, and sleep studies, are often performed in hospitals. For effective assessment, these procedures frequently necessitate the use of specialized respiratory care devices.

Companies Covered in this report:

Koninklijke Philips N.V., Medtronic Inc, Masimo Corporation, Cardinal Health, Inc, Medline Industries, Baxter International Inc., Stryker Corporation, Siemens AG, GE HealthCare Technologies, Inc, Getinge AB, ResMed Inc., Fisher & Paykel Healthcare Corporation Limited.

Considered in this report:

• Geography: North America
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• North America Respiratory Care Devices market Outlook with its value and forecast along with its segments
• Country-wise Respiratory Care Devices market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United States
• Canada
• Mexico

By Product Type:

• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:

• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:

• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.